CAPG is significantly overexpressed in CRC and correlates with poor prognosis, while its knockdown inhibits CRC cell growth, induces cell cycle arrest, and promotes apoptosis and ferroptosis via the upregulation of the P53 pathway. This evidence concerns the gene TP53 and colorectal carcinoma.